MAY 15 2018 QIAGEN N.V. announces that it will initiate the repurchase of a first tranche of shares under the share repurchase program which was announced by an ad hoc announcement dated January 31, 2018. In the time period between May 15, 2018 until August 20, 2018, at the latest, a first tranche of up... Read more
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited 1st quarter 2018 revenues of approximately $712,000, representing a 286% increase from the same quarter in the prior year. Drivers of revenue growth that have been... Read more
14 May 2018 Oxford Instruments is delighted to announce Dr Philip Moll of Max Plank Institute for Chemical Physics of Solids in Dresden, Germany – as the winner of the 2018 Nicholas Kurti Science Prize for Europe. His research group, ‘microstructured quantum materials’ (mqm), is currently transitioning to the Institute of Materials at EPFL, Switzerland.... Read more
Burlington, MA 14 May 2018. Following the introduction of the AQS3™pro, a new protein characterization platform that allows users to ‘See Change™, in the secondary structure of proteins, RedShiftBio has announced that it is expanding its team with key hires. The growth will enable the company to fulfil high demand for the new instrument. John... Read more
CHELMSFORD, Mass., May 14, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the 19th Annual B. Riley FBR Investor Conference at the Loews Hotel, Santa Monica, CA. Lindon Robertson, Chief Financial Officer, will present on Thursday, May 24th at 8:30 a.m. Pacific Time. Analysts, investors and members of the... Read more
Basel, 14 May 2018 Roche to present new phase III data for Hemlibra in people with haemophilia A at the World Federation of Hemophilia 2018 World Congress Data include results from HAVEN 3 study in people with haemophilia A without factor VIII inhibitors and HAVEN 4 study in people with haemophilia A with or without... Read more
Basel, 14 May 2018 Roche to present new phase III data for Hemlibra in people with haemophilia A at the World Federation of Hemophilia 2018 World Congress Data include results from HAVEN 3 study in people with haemophilia A without factor VIII inhibitors and HAVEN 4 study in people with haemophilia A with or without... Read more
EDEN PRAIRIE, Minn., May 10, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced that Dr. Jeffrey Graves, President and CEO, will make a presentation to the investment community at the 19th Annual B. Riley FBR Investor Conference on Thursday, May 24, at 8:30 a.m. PT, at... Read more
Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more
PDF Version SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent directors, granted equity awards effective as of May 8, 2018, under Fluidigm’s 2017 Inducement Award Plan (Plan), as a material inducement to three individuals entering into employment with Fluidigm. The equity... Read more